Longitudinal assessment of preoperative dexamethasone administration on cognitive function after cardiac surgery: a 4-year follow‐up of a randomized controlled trial

BMC Anesthesiology - Tập 21 - Trang 1-8 - 2021
Sandro Glumac1, Goran Kardum2, Lidija Sodic3, Cristijan Bulat4, Ivan Covic5, Mladen Carev1,6, Nenad Karanovic1,6
1Department of Anesthesiology and Intensive Care, University Hospital of Split, Split, Croatia
2Department of Psychology, Faculty of Humanities and Social Sciences, University of Split, Split, Croatia
3Department of Neurology, University Hospital of Split, Split, Croatia
4Department of Cardiac Surgery, University Hospital of Split, Split, Croatia
5School of Medicine, University of Split, Split, Croatia
6Department of Anesthesiology and Intensive Medicine, School of Medicine, University of Split, Split, Croatia

Tóm tắt

The pathogenesis of postoperative cognitive decline (POCD) is still poorly understood; however, the inflammatory response to surgical procedures seems likely to be involved. In addition, our recent randomized controlled trial showed that perioperative corticosteroid treatment may ameliorate early POCD after cardiac surgery. To assess the long-term effect of dexamethasone administration on cognitive function, we conducted a 4-year follow-up. The patients were randomized to receive a single intravenous bolus of 0.1 mg kg− 1 dexamethasone or placebo 10 h before elective cardiac surgery. The endpoint in both groups was POCD incidence on the 6th day and four years postoperatively. Of the 161 patients analyzed previously, the current follow-up included 116 patients. Compared to the 62 patients in the placebo group, the 54 patients in the dexamethasone group showed a lower incidence of POCD on the 6th day (relative risk (RR), 0.510; 95 % confidence interval (CI), 0.241 to 1.079; p = 0.067, time interval also analyzed previously) and four years (RR, 0.459; 95 % CI, 0.192 to 1.100; p = 0.068) after cardiac surgery. The change in cognitive status between the two postoperative measurements was not significant (p = 0.010) among the patients in the dexamethasone group, in contrast to patients in the placebo group (p = 0.673). Although statistical significance was not reached in the current study, the prophylactic administration of dexamethasone seems to be useful to prevent POCD development following cardiac surgery. However, further large multicenter research is needed to confirm these directions. ClinicalTrials.gov identifier: NCT02767713 (10/05/2016).

Tài liệu tham khảo

Olesen ND, Frederiksen HJ, Storkholm JH, et al. Internal carotid artery blood flow is enhanced by elevating blood pressure during combined propofol-remifentanil and thoracic epidural anaesthesia: A randomised cross-over trial. Eur J Anaesthesiol. 2020;37:482–90. Glumac S, Kardum G, Karanovic N. Postoperative cognitive decline after cardiac surgery: A narrative review of current knowledge in 2019. Med Sci Monit. 2019;25:3262–70. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395–2. Bollen Pinto B, Chew M, Lurati Buse G, Walder B. The concept of peri-operative medicine to prevent major adverse events and improve outcome in surgical patients: A narrative review. Eur J Anaesthesiol. 2019;36:889–3. Olotu C. Postoperative neurocognitive disorders. Curr Opin Anaesthesiol. 2020;33:101–8. Alifier M, Olsson B, Andreasson U, et al. Cardiac surgery is associated with biomarker evidence of neuronal damage. J Alzheimers Dis. 2020;74:1211–20. O’Gara BP, Mueller A, Gasangwa DVI, et al. Prevention of early postoperative decline: A randomized, controlled feasibility trial of perioperative cognitive training. Anesth Analg. 2020;130:586–95. Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368:1179–88. Patel N, Minhas JS, Chung EM. Intraoperative embolization and cognitive decline after cardiac surgery: A systematic review. Semin Cardiothorac Vasc Anesth. 2016;20:225–31. Steinmetz J, Rasmussen LS. Peri-operative cognitive dysfunction and protection. Anaesthesia. 2016;71:58–63. Shaefi S, Shankar P, Mueller AL, et al. Intraoperative oxygen concentration and neurocognition after cardiac surgery. Anesthesiology. 2021;134:189–201. Larsen MH, Draegert C, Vedel AG, et al. Long-term survival and cognitive function according to blood pressure management during cardiac surgery. A follow-up. Acta Anaesthesiol Scand. 2020;64:936–44. Feng X, Hu J, Hua F, Zhang J, Zhang L, Xu G. The correlation of intraoperative hypotension and postoperative cognitive impairment: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2020;20:193. Gorvitovskaia AY, Scrimgeour LA, Potz BA, et al. Lower preoperative hematocrit, longer hospital stay, and neurocognitive decline after cardiac surgery. Surgery. 2020;168:147–54. Subramaniyan S, Terrando N. Neuroinflammation and perioperative neurocognitive disorders. Anesth Analg. 2019;128:781–88. Glumac S, Kardum G, Sodic L, Supe-Domic D, Karanovic N. Effects of dexamethasone on early cognitive decline after cardiac surgery: A randomised controlled trial. Eur J Anaesthesiol. 2017;34:776–84. Valentin LS, Pereira VF, Pietrobon RS, et al. Effects of single low dose of dexamethasone before noncardiac and nonneurologic surgery and general anesthesia on postoperative cognitive dysfunction-A phase III double blind, randomized clinical trial. PLoS One. 2016;11:e0152308. Ottens TH, Dieleman JM, Sauër AM, et al. Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial. Anesthesiology. 2014;121:492–0. Dieleman JM, de Wit GA, Nierich AP, et al. Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial. Anaesthesia. 2017;72:704–13. Royse CF, Saager L, Whitlock R, et al. Impact of methylprednisolone on postoperative quality of recovery and delirium in the steroids in cardiac surgery trial: A randomized, double-blind, placebo-controlled substudy. Anesthesiology. 2017;126:223–33. Whitlock RP, Devereaux PJ, Teoh KH, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386:1243–53. Relander K, Hietanen M, Rantanen K, et al. Postoperative cognitive change after cardiac surgery predicts long-term cognitive outcome. Brain Behav. 2020;10:e01750. Greaves D, Psaltis PJ, Ross TJ, et al. Cognitive outcomes following coronary artery bypass grafting: A systematic review and meta-analysis of 91,829 patients. Int J Cardiol. 2019;289:43–49. Belrose JC, Noppens RR. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiol. 2019;19:241. Robert C, Soulier A, Sciard D, et al. Cognitive status of patients judged fit for discharge from the post-anaesthesia care unit after general anaesthesia: a randomized comparison between desflurane and propofol. BMC Anesthesiol. 2021;21:76. Glumac S, Kardum G, Karanovic N. Reply to: dexamethasone and postoperative cognitive decline. Eur J Anaesthesiol. 2018;35:635–36. Evered L, Silbert B, Knopman DS, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Can J Anaesth. 2018;65:1248–57.